nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—SLCO1A2—Prednisolone—multiple sclerosis	0.0908	0.136	CbGbCtD
Bumetanide—PTGS2—Triamcinolone—multiple sclerosis	0.0879	0.131	CbGbCtD
Bumetanide—SLCO1A2—Prednisone—multiple sclerosis	0.0857	0.128	CbGbCtD
Bumetanide—PTGS2—Betamethasone—multiple sclerosis	0.0754	0.113	CbGbCtD
Bumetanide—SLC22A11—Methotrexate—multiple sclerosis	0.0644	0.0962	CbGbCtD
Bumetanide—SLC22A7—Methotrexate—multiple sclerosis	0.0614	0.0916	CbGbCtD
Bumetanide—SLCO1A2—Dexamethasone—multiple sclerosis	0.0535	0.0799	CbGbCtD
Bumetanide—PTGS2—Dexamethasone—multiple sclerosis	0.0439	0.0655	CbGbCtD
Bumetanide—SLCO1A2—Methotrexate—multiple sclerosis	0.043	0.0642	CbGbCtD
Bumetanide—SLC22A8—Methotrexate—multiple sclerosis	0.0375	0.0559	CbGbCtD
Bumetanide—SLC22A6—Methotrexate—multiple sclerosis	0.0261	0.039	CbGbCtD
Bumetanide—SLC12A5—peripheral nervous system—multiple sclerosis	0.0146	0.102	CbGeAlD
Bumetanide—SLC12A5—nerve—multiple sclerosis	0.0114	0.0797	CbGeAlD
Bumetanide—SLC12A5—brainstem—multiple sclerosis	0.0049	0.0342	CbGeAlD
Bumetanide—SLC12A5—retina—multiple sclerosis	0.00473	0.033	CbGeAlD
Bumetanide—SLC12A4—brainstem—multiple sclerosis	0.00407	0.0284	CbGeAlD
Bumetanide—Liver injury—Fingolimod—multiple sclerosis	0.00403	0.0344	CcSEcCtD
Bumetanide—SLC12A4—retina—multiple sclerosis	0.00393	0.0274	CbGeAlD
Bumetanide—SLC12A5—medulla oblongata—multiple sclerosis	0.00342	0.0239	CbGeAlD
Bumetanide—PTGS2—leg—multiple sclerosis	0.00333	0.0232	CbGeAlD
Bumetanide—SLC12A5—midbrain—multiple sclerosis	0.00312	0.0218	CbGeAlD
Bumetanide—SLC12A5—spinal cord—multiple sclerosis	0.00305	0.0213	CbGeAlD
Bumetanide—CA4—nerve—multiple sclerosis	0.00295	0.0206	CbGeAlD
Bumetanide—SLC12A2—brainstem—multiple sclerosis	0.00281	0.0196	CbGeAlD
Bumetanide—SLC12A4—midbrain—multiple sclerosis	0.00259	0.0181	CbGeAlD
Bumetanide—SLC12A5—nervous system—multiple sclerosis	0.00257	0.0179	CbGeAlD
Bumetanide—SLC12A4—spinal cord—multiple sclerosis	0.00253	0.0177	CbGeAlD
Bumetanide—SLC12A5—central nervous system—multiple sclerosis	0.00247	0.0173	CbGeAlD
Bumetanide—SLC12A5—cerebellum—multiple sclerosis	0.00242	0.0169	CbGeAlD
Bumetanide—Blood disorder—Cladribine—multiple sclerosis	0.0023	0.0197	CcSEcCtD
Bumetanide—Electrolyte imbalance—Methylprednisolone—multiple sclerosis	0.00228	0.0194	CcSEcCtD
Bumetanide—SLC12A4—nervous system—multiple sclerosis	0.00213	0.0149	CbGeAlD
Bumetanide—Hyperuricaemia—Cladribine—multiple sclerosis	0.00207	0.0177	CcSEcCtD
Bumetanide—Electrolyte imbalance—Betamethasone—multiple sclerosis	0.00207	0.0177	CcSEcCtD
Bumetanide—Electrolyte imbalance—Dexamethasone—multiple sclerosis	0.00207	0.0177	CcSEcCtD
Bumetanide—Cholestasis—Azathioprine—multiple sclerosis	0.00206	0.0176	CcSEcCtD
Bumetanide—Serum creatinine increased—Mitoxantrone—multiple sclerosis	0.00205	0.0175	CcSEcCtD
Bumetanide—SLC12A4—central nervous system—multiple sclerosis	0.00205	0.0143	CbGeAlD
Bumetanide—SLC12A4—cerebellum—multiple sclerosis	0.00201	0.014	CbGeAlD
Bumetanide—CA7—midbrain—multiple sclerosis	0.00201	0.014	CbGeAlD
Bumetanide—SLC12A5—brain—multiple sclerosis	0.00196	0.0137	CbGeAlD
Bumetanide—SLC12A2—medulla oblongata—multiple sclerosis	0.00196	0.0137	CbGeAlD
Bumetanide—Blood uric acid increased—Cladribine—multiple sclerosis	0.00196	0.0167	CcSEcCtD
Bumetanide—Musculoskeletal pain—Cladribine—multiple sclerosis	0.00194	0.0166	CcSEcCtD
Bumetanide—Liver injury—Azathioprine—multiple sclerosis	0.00186	0.0159	CcSEcCtD
Bumetanide—CA14—medulla oblongata—multiple sclerosis	0.00183	0.0128	CbGeAlD
Bumetanide—SLC12A2—midbrain—multiple sclerosis	0.00179	0.0125	CbGeAlD
Bumetanide—SLC12A2—spinal cord—multiple sclerosis	0.00175	0.0122	CbGeAlD
Bumetanide—CA14—midbrain—multiple sclerosis	0.00167	0.0117	CbGeAlD
Bumetanide—CA14—spinal cord—multiple sclerosis	0.00163	0.0114	CbGeAlD
Bumetanide—SLC12A4—brain—multiple sclerosis	0.00163	0.0114	CbGeAlD
Bumetanide—Hepatocellular injury—Azathioprine—multiple sclerosis	0.00156	0.0133	CcSEcCtD
Bumetanide—CA7—cerebellum—multiple sclerosis	0.00155	0.0108	CbGeAlD
Bumetanide—SLC12A2—nervous system—multiple sclerosis	0.00147	0.0103	CbGeAlD
Bumetanide—SLC12A1—spinal cord—multiple sclerosis	0.00146	0.0102	CbGeAlD
Bumetanide—SLC12A2—central nervous system—multiple sclerosis	0.00142	0.00989	CbGeAlD
Bumetanide—SLC10A1—nervous system—multiple sclerosis	0.00139	0.0097	CbGeAlD
Bumetanide—SLC12A2—cerebellum—multiple sclerosis	0.00138	0.00966	CbGeAlD
Bumetanide—CA9—cerebellum—multiple sclerosis	0.00136	0.00951	CbGeAlD
Bumetanide—Hyperuricaemia—Mitoxantrone—multiple sclerosis	0.00136	0.0116	CcSEcCtD
Bumetanide—SLC10A1—central nervous system—multiple sclerosis	0.00134	0.00934	CbGeAlD
Bumetanide—Leukopenia—Fingolimod—multiple sclerosis	0.00133	0.0113	CcSEcCtD
Bumetanide—CA14—cerebellum—multiple sclerosis	0.00129	0.00903	CbGeAlD
Bumetanide—Blood uric acid increased—Mitoxantrone—multiple sclerosis	0.00129	0.011	CcSEcCtD
Bumetanide—CFTR—brain—multiple sclerosis	0.00128	0.00894	CbGeAlD
Bumetanide—CA4—brainstem—multiple sclerosis	0.00127	0.00884	CbGeAlD
Bumetanide—CA7—brain—multiple sclerosis	0.00126	0.0088	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Cladribine—multiple sclerosis	0.00126	0.0107	CcSEcCtD
Bumetanide—SLC12A1—nervous system—multiple sclerosis	0.00123	0.00861	CbGeAlD
Bumetanide—SLC12A1—central nervous system—multiple sclerosis	0.00119	0.00829	CbGeAlD
Bumetanide—Azotaemia—Methotrexate—multiple sclerosis	0.00118	0.0101	CcSEcCtD
Bumetanide—Glycosuria—Triamcinolone—multiple sclerosis	0.00118	0.01	CcSEcCtD
Bumetanide—Glycosuria—Methylprednisolone—multiple sclerosis	0.00117	0.01	CcSEcCtD
Bumetanide—Abdominal discomfort—Cladribine—multiple sclerosis	0.00116	0.00987	CcSEcCtD
Bumetanide—Hypotension—Fingolimod—multiple sclerosis	0.00113	0.00966	CcSEcCtD
Bumetanide—SLC12A2—brain—multiple sclerosis	0.00112	0.00785	CbGeAlD
Bumetanide—CA12—nervous system—multiple sclerosis	0.00107	0.00748	CbGeAlD
Bumetanide—Glycosuria—Betamethasone—multiple sclerosis	0.00107	0.00912	CcSEcCtD
Bumetanide—Glycosuria—Dexamethasone—multiple sclerosis	0.00107	0.00912	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00107	0.0091	CcSEcCtD
Bumetanide—SLC10A1—brain—multiple sclerosis	0.00106	0.00742	CbGeAlD
Bumetanide—Renal failure—Cladribine—multiple sclerosis	0.00106	0.00903	CcSEcCtD
Bumetanide—CA14—brain—multiple sclerosis	0.00105	0.00733	CbGeAlD
Bumetanide—Fatigue—Fingolimod—multiple sclerosis	0.00104	0.00891	CcSEcCtD
Bumetanide—CA12—central nervous system—multiple sclerosis	0.00103	0.0072	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Azathioprine—multiple sclerosis	0.00102	0.00873	CcSEcCtD
Bumetanide—SLCO1A2—medulla oblongata—multiple sclerosis	0.000998	0.00697	CbGeAlD
Bumetanide—Encephalopathy—Methotrexate—multiple sclerosis	0.00098	0.00838	CcSEcCtD
Bumetanide—CA5B—nervous system—multiple sclerosis	0.000961	0.00671	CbGeAlD
Bumetanide—Pancreatitis—Azathioprine—multiple sclerosis	0.000961	0.00821	CcSEcCtD
Bumetanide—SLC22A7—brain—multiple sclerosis	0.000947	0.00661	CbGeAlD
Bumetanide—SLC12A1—brain—multiple sclerosis	0.000943	0.00658	CbGeAlD
Bumetanide—Abdominal discomfort—Azathioprine—multiple sclerosis	0.00094	0.00803	CcSEcCtD
Bumetanide—Glycosuria—Prednisone—multiple sclerosis	0.000929	0.00794	CcSEcCtD
Bumetanide—CA5B—central nervous system—multiple sclerosis	0.000925	0.00646	CbGeAlD
Bumetanide—Hyponatraemia—Mitoxantrone—multiple sclerosis	0.00092	0.00786	CcSEcCtD
Bumetanide—SLC22A6—brain—multiple sclerosis	0.000914	0.00638	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000914	0.159	CbGdCrCtD
Bumetanide—SLCO1A2—midbrain—multiple sclerosis	0.000912	0.00637	CbGeAlD
Bumetanide—Erythema multiforme—Cladribine—multiple sclerosis	0.000912	0.00779	CcSEcCtD
Bumetanide—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000899	0.156	CbGdCrCtD
Bumetanide—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000899	0.156	CbGdCrCtD
Bumetanide—SLCO1A2—spinal cord—multiple sclerosis	0.00089	0.00621	CbGeAlD
Bumetanide—CA4—medulla oblongata—multiple sclerosis	0.000883	0.00616	CbGeAlD
Bumetanide—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000879	0.153	CbGdCrCtD
Bumetanide—Asthenia—Fingolimod—multiple sclerosis	0.000868	0.00741	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.000866	0.0074	CcSEcCtD
Bumetanide—Blood creatinine increased—Mitoxantrone—multiple sclerosis	0.000859	0.00734	CcSEcCtD
Bumetanide—Pruritus—Fingolimod—multiple sclerosis	0.000855	0.00731	CcSEcCtD
Bumetanide—Dehydration—Mitoxantrone—multiple sclerosis	0.000852	0.00728	CcSEcCtD
Bumetanide—Hypokalaemia—Mitoxantrone—multiple sclerosis	0.000834	0.00713	CcSEcCtD
Bumetanide—Diarrhoea—Fingolimod—multiple sclerosis	0.000827	0.00707	CcSEcCtD
Bumetanide—CA12—brain—multiple sclerosis	0.000819	0.00572	CbGeAlD
Bumetanide—CA4—midbrain—multiple sclerosis	0.000807	0.00563	CbGeAlD
Bumetanide—Dizziness—Fingolimod—multiple sclerosis	0.0008	0.00683	CcSEcCtD
Bumetanide—CA4—spinal cord—multiple sclerosis	0.000787	0.0055	CbGeAlD
Bumetanide—Headache—Fingolimod—multiple sclerosis	0.000757	0.00647	CcSEcCtD
Bumetanide—SLCO1A2—nervous system—multiple sclerosis	0.00075	0.00523	CbGeAlD
Bumetanide—Erythema multiforme—Azathioprine—multiple sclerosis	0.000742	0.00634	CcSEcCtD
Bumetanide—CA5B—brain—multiple sclerosis	0.000735	0.00513	CbGeAlD
Bumetanide—SLCO1A2—central nervous system—multiple sclerosis	0.000722	0.00504	CbGeAlD
Bumetanide—SLC22A8—nervous system—multiple sclerosis	0.000716	0.005	CbGeAlD
Bumetanide—Arthralgia—Cladribine—multiple sclerosis	0.000715	0.00611	CcSEcCtD
Bumetanide—Chest pain—Cladribine—multiple sclerosis	0.000715	0.00611	CcSEcCtD
Bumetanide—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.000715	0.00611	CcSEcCtD
Bumetanide—SLCO1A2—cerebellum—multiple sclerosis	0.000706	0.00493	CbGeAlD
Bumetanide—Renal failure—Mitoxantrone—multiple sclerosis	0.000694	0.00593	CcSEcCtD
Bumetanide—SLC22A8—central nervous system—multiple sclerosis	0.000689	0.00481	CbGeAlD
Bumetanide—Hyperuricaemia—Methotrexate—multiple sclerosis	0.000678	0.0058	CcSEcCtD
Bumetanide—Sweating—Mitoxantrone—multiple sclerosis	0.000677	0.00579	CcSEcCtD
Bumetanide—Thrombocytopenia—Cladribine—multiple sclerosis	0.000671	0.00573	CcSEcCtD
Bumetanide—CA4—nervous system—multiple sclerosis	0.000663	0.00463	CbGeAlD
Bumetanide—Hyperhidrosis—Cladribine—multiple sclerosis	0.000663	0.00566	CcSEcCtD
Bumetanide—Blood uric acid increased—Methotrexate—multiple sclerosis	0.000641	0.00547	CcSEcCtD
Bumetanide—Hypotension—Cladribine—multiple sclerosis	0.00064	0.00547	CcSEcCtD
Bumetanide—CA4—central nervous system—multiple sclerosis	0.000639	0.00446	CbGeAlD
Bumetanide—Pancreatitis—Prednisolone—multiple sclerosis	0.000637	0.00545	CcSEcCtD
Bumetanide—CA4—cerebellum—multiple sclerosis	0.000624	0.00436	CbGeAlD
Bumetanide—Leukopenia—Azathioprine—multiple sclerosis	0.000611	0.00522	CcSEcCtD
Bumetanide—Fatigue—Cladribine—multiple sclerosis	0.000591	0.00505	CcSEcCtD
Bumetanide—Furosemide—ALB—multiple sclerosis	0.000588	0.582	CrCbGaD
Bumetanide—Pancreatitis—Triamcinolone—multiple sclerosis	0.000586	0.00501	CcSEcCtD
Bumetanide—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000585	0.005	CcSEcCtD
Bumetanide—Arthralgia—Azathioprine—multiple sclerosis	0.000581	0.00497	CcSEcCtD
Bumetanide—SLCO1A2—brain—multiple sclerosis	0.000573	0.004	CbGeAlD
Bumetanide—Hypokalaemia—Dexamethasone—multiple sclerosis	0.000571	0.00488	CcSEcCtD
Bumetanide—Hypokalaemia—Betamethasone—multiple sclerosis	0.000571	0.00488	CcSEcCtD
Bumetanide—Gynaecomastia—Methotrexate—multiple sclerosis	0.000563	0.00481	CcSEcCtD
Bumetanide—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00056	0.00479	CcSEcCtD
Bumetanide—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000551	0.0957	CbGdCrCtD
Bumetanide—SLC22A8—brain—multiple sclerosis	0.000547	0.00382	CbGeAlD
Bumetanide—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000546	0.00466	CcSEcCtD
Bumetanide—Urticaria—Cladribine—multiple sclerosis	0.000545	0.00465	CcSEcCtD
Bumetanide—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000543	0.0942	CbGdCrCtD
Bumetanide—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000543	0.0942	CbGdCrCtD
Bumetanide—Abdominal pain—Cladribine—multiple sclerosis	0.000542	0.00463	CcSEcCtD
Bumetanide—PTGS2—medulla oblongata—multiple sclerosis	0.000541	0.00377	CbGeAlD
Bumetanide—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00053	0.0921	CbGdCrCtD
Bumetanide—Hypotension—Azathioprine—multiple sclerosis	0.000521	0.00445	CcSEcCtD
Bumetanide—Polyuria—Methotrexate—multiple sclerosis	0.00052	0.00444	CcSEcCtD
Bumetanide—Sweating—Methylprednisolone—multiple sclerosis	0.00051	0.00436	CcSEcCtD
Bumetanide—CA4—brain—multiple sclerosis	0.000507	0.00354	CbGeAlD
Bumetanide—Hypokalaemia—Prednisone—multiple sclerosis	0.000497	0.00425	CcSEcCtD
Bumetanide—Leukopenia—Mitoxantrone—multiple sclerosis	0.000494	0.00422	CcSEcCtD
Bumetanide—PTGS2—midbrain—multiple sclerosis	0.000494	0.00345	CbGeAlD
Bumetanide—Asthenia—Cladribine—multiple sclerosis	0.000492	0.0042	CcSEcCtD
Bumetanide—Hyperglycaemia—Betamethasone—multiple sclerosis	0.000489	0.00418	CcSEcCtD
Bumetanide—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.000489	0.00418	CcSEcCtD
Bumetanide—Pruritus—Cladribine—multiple sclerosis	0.000485	0.00414	CcSEcCtD
Bumetanide—PTGS2—spinal cord—multiple sclerosis	0.000482	0.00336	CbGeAlD
Bumetanide—Chest pain—Mitoxantrone—multiple sclerosis	0.00047	0.00402	CcSEcCtD
Bumetanide—Arthralgia—Mitoxantrone—multiple sclerosis	0.00047	0.00402	CcSEcCtD
Bumetanide—Diarrhoea—Cladribine—multiple sclerosis	0.000469	0.00401	CcSEcCtD
Bumetanide—Pancreatitis—Prednisone—multiple sclerosis	0.000463	0.00396	CcSEcCtD
Bumetanide—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000456	0.00389	CcSEcCtD
Bumetanide—Dizziness—Cladribine—multiple sclerosis	0.000453	0.00387	CcSEcCtD
Bumetanide—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000441	0.00377	CcSEcCtD
Bumetanide—Abdominal pain—Azathioprine—multiple sclerosis	0.000441	0.00376	CcSEcCtD
Bumetanide—Vomiting—Cladribine—multiple sclerosis	0.000436	0.00372	CcSEcCtD
Bumetanide—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000436	0.00372	CcSEcCtD
Bumetanide—Rash—Cladribine—multiple sclerosis	0.000432	0.00369	CcSEcCtD
Bumetanide—Dermatitis—Cladribine—multiple sclerosis	0.000432	0.00369	CcSEcCtD
Bumetanide—Headache—Cladribine—multiple sclerosis	0.000429	0.00367	CcSEcCtD
Bumetanide—Hyperglycaemia—Prednisone—multiple sclerosis	0.000426	0.00364	CcSEcCtD
Bumetanide—Fenoprofen—ALB—multiple sclerosis	0.000422	0.418	CrCbGaD
Bumetanide—Hypotension—Mitoxantrone—multiple sclerosis	0.000421	0.0036	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000411	0.00351	CcSEcCtD
Bumetanide—Nausea—Cladribine—multiple sclerosis	0.000407	0.00348	CcSEcCtD
Bumetanide—Vertigo—Prednisolone—multiple sclerosis	0.000407	0.00348	CcSEcCtD
Bumetanide—PTGS2—nervous system—multiple sclerosis	0.000406	0.00284	CbGeAlD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000391	0.00617	CbGpPWpGaD
Bumetanide—PTGS2—central nervous system—multiple sclerosis	0.000391	0.00273	CbGeAlD
Bumetanide—Fatigue—Mitoxantrone—multiple sclerosis	0.000388	0.00332	CcSEcCtD
Bumetanide—Pancreatitis—Methotrexate—multiple sclerosis	0.000387	0.00331	CcSEcCtD
Bumetanide—PTGS2—cerebellum—multiple sclerosis	0.000382	0.00267	CbGeAlD
Bumetanide—Diarrhoea—Azathioprine—multiple sclerosis	0.000381	0.00326	CcSEcCtD
Bumetanide—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000378	0.00323	CcSEcCtD
Bumetanide—Vertigo—Triamcinolone—multiple sclerosis	0.000374	0.0032	CcSEcCtD
Bumetanide—Vertigo—Methylprednisolone—multiple sclerosis	0.000373	0.00319	CcSEcCtD
Bumetanide—Dizziness—Azathioprine—multiple sclerosis	0.000369	0.00315	CcSEcCtD
Bumetanide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000368	0.00315	CcSEcCtD
Bumetanide—Urticaria—Mitoxantrone—multiple sclerosis	0.000358	0.00306	CcSEcCtD
Bumetanide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000357	0.00305	CcSEcCtD
Bumetanide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000356	0.00304	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000355	0.0056	CbGpPWpGaD
Bumetanide—Vomiting—Azathioprine—multiple sclerosis	0.000354	0.00303	CcSEcCtD
Bumetanide—Arthralgia—Methylprednisolone—multiple sclerosis	0.000354	0.00302	CcSEcCtD
Bumetanide—Rash—Azathioprine—multiple sclerosis	0.000351	0.003	CcSEcCtD
Bumetanide—Dermatitis—Azathioprine—multiple sclerosis	0.000351	0.003	CcSEcCtD
Bumetanide—Headache—Azathioprine—multiple sclerosis	0.000349	0.00298	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000349	0.00298	CcSEcCtD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000349	0.0055	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000349	0.0055	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000349	0.0055	CbGpPWpGaD
Bumetanide—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000348	0.00549	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000347	0.00548	CbGpPWpGaD
Bumetanide—Dry mouth—Triamcinolone—multiple sclerosis	0.000347	0.00296	CcSEcCtD
Bumetanide—Renal failure—Methotrexate—multiple sclerosis	0.000346	0.00296	CcSEcCtD
Bumetanide—Vertigo—Betamethasone—multiple sclerosis	0.00034	0.0029	CcSEcCtD
Bumetanide—Vertigo—Dexamethasone—multiple sclerosis	0.00034	0.0029	CcSEcCtD
Bumetanide—Sweating—Methotrexate—multiple sclerosis	0.000337	0.00288	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000336	0.00529	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000333	0.00526	CbGpPWpGaD
Bumetanide—Nausea—Azathioprine—multiple sclerosis	0.000331	0.00283	CcSEcCtD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	0.000331	0.00522	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000329	0.00281	CcSEcCtD
Bumetanide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000328	0.0028	CcSEcCtD
Bumetanide—Asthenia—Mitoxantrone—multiple sclerosis	0.000323	0.00276	CcSEcCtD
Bumetanide—Hypotension—Methylprednisolone—multiple sclerosis	0.000317	0.00271	CcSEcCtD
Bumetanide—PTGS2—brain—multiple sclerosis	0.00031	0.00217	CbGeAlD
Bumetanide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000308	0.00263	CcSEcCtD
Bumetanide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000302	0.00258	CcSEcCtD
Bumetanide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000302	0.00258	CcSEcCtD
Bumetanide—Erythema multiforme—Methotrexate—multiple sclerosis	0.000299	0.00255	CcSEcCtD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000298	0.00471	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000298	0.00255	CcSEcCtD
Bumetanide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000298	0.00255	CcSEcCtD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000297	0.00468	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000296	0.00468	CbGpPWpGaD
Bumetanide—Vertigo—Prednisone—multiple sclerosis	0.000296	0.00253	CcSEcCtD
Bumetanide—Urticaria—Prednisolone—multiple sclerosis	0.000294	0.00251	CcSEcCtD
Bumetanide—Fatigue—Triamcinolone—multiple sclerosis	0.000293	0.0025	CcSEcCtD
Bumetanide—Fatigue—Methylprednisolone—multiple sclerosis	0.000292	0.0025	CcSEcCtD
Bumetanide—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00029	0.00458	CbGpPWpGaD
Bumetanide—Hypotension—Betamethasone—multiple sclerosis	0.000288	0.00246	CcSEcCtD
Bumetanide—Hypotension—Dexamethasone—multiple sclerosis	0.000288	0.00246	CcSEcCtD
Bumetanide—Vomiting—Mitoxantrone—multiple sclerosis	0.000286	0.00245	CcSEcCtD
Bumetanide—Rash—Mitoxantrone—multiple sclerosis	0.000284	0.00243	CcSEcCtD
Bumetanide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000284	0.00243	CcSEcCtD
Bumetanide—Headache—Mitoxantrone—multiple sclerosis	0.000282	0.00241	CcSEcCtD
Bumetanide—Arthralgia—Prednisone—multiple sclerosis	0.00028	0.00239	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000277	0.00237	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	0.000274	0.00432	CbGpPWpGaD
Bumetanide—Urticaria—Triamcinolone—multiple sclerosis	0.00027	0.00231	CcSEcCtD
Bumetanide—Urticaria—Methylprednisolone—multiple sclerosis	0.000269	0.0023	CcSEcCtD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000269	0.00424	CbGpPWpGaD
Bumetanide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000268	0.00229	CcSEcCtD
Bumetanide—Nausea—Mitoxantrone—multiple sclerosis	0.000268	0.00229	CcSEcCtD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000267	0.00422	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000267	0.00422	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	0.000266	0.0042	CbGpPWpGaD
Bumetanide—Fatigue—Dexamethasone—multiple sclerosis	0.000266	0.00227	CcSEcCtD
Bumetanide—Fatigue—Betamethasone—multiple sclerosis	0.000266	0.00227	CcSEcCtD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000265	0.00418	CbGpPWpGaD
Bumetanide—Hyperhidrosis—Prednisone—multiple sclerosis	0.00026	0.00222	CcSEcCtD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000252	0.00398	CbGpPWpGaD
Bumetanide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000252	0.00216	CcSEcCtD
Bumetanide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000252	0.00216	CcSEcCtD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000249	0.00393	CbGpPWpGaD
Bumetanide—SLC12A5—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000247	0.0039	CbGpPWpGaD
Bumetanide—SLC12A4—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000247	0.0039	CbGpPWpGaD
Bumetanide—Vertigo—Methotrexate—multiple sclerosis	0.000247	0.00211	CcSEcCtD
Bumetanide—Leukopenia—Methotrexate—multiple sclerosis	0.000246	0.0021	CcSEcCtD
Bumetanide—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	0.000246	0.00388	CbGpPWpGaD
Bumetanide—Urticaria—Betamethasone—multiple sclerosis	0.000245	0.00209	CcSEcCtD
Bumetanide—Urticaria—Dexamethasone—multiple sclerosis	0.000245	0.00209	CcSEcCtD
Bumetanide—Dizziness—Prednisolone—multiple sclerosis	0.000244	0.00209	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	0.000244	0.00385	CbGpPWpGaD
Bumetanide—Asthenia—Triamcinolone—multiple sclerosis	0.000244	0.00208	CcSEcCtD
Bumetanide—Abdominal pain—Betamethasone—multiple sclerosis	0.000244	0.00208	CcSEcCtD
Bumetanide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000244	0.00208	CcSEcCtD
Bumetanide—Asthenia—Methylprednisolone—multiple sclerosis	0.000243	0.00208	CcSEcCtD
Bumetanide—Pruritus—Triamcinolone—multiple sclerosis	0.00024	0.00206	CcSEcCtD
Bumetanide—Pruritus—Methylprednisolone—multiple sclerosis	0.00024	0.00205	CcSEcCtD
Bumetanide—CA14—Metabolism—SRM—multiple sclerosis	0.00024	0.00379	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	0.000238	0.00375	CbGpPWpGaD
Bumetanide—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	0.000235	0.00371	CbGpPWpGaD
Bumetanide—Chest pain—Methotrexate—multiple sclerosis	0.000234	0.002	CcSEcCtD
Bumetanide—Arthralgia—Methotrexate—multiple sclerosis	0.000234	0.002	CcSEcCtD
Bumetanide—CA5A—Metabolism—SRM—multiple sclerosis	0.000234	0.00369	CbGpPWpGaD
Bumetanide—Rash—Prednisolone—multiple sclerosis	0.000233	0.00199	CcSEcCtD
Bumetanide—Dermatitis—Prednisolone—multiple sclerosis	0.000233	0.00199	CcSEcCtD
Bumetanide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000232	0.00198	CcSEcCtD
Bumetanide—Fatigue—Prednisone—multiple sclerosis	0.000232	0.00198	CcSEcCtD
Bumetanide—Headache—Prednisolone—multiple sclerosis	0.000232	0.00198	CcSEcCtD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	0.000228	0.00359	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000226	0.00357	CbGpPWpGaD
Bumetanide—Dizziness—Triamcinolone—multiple sclerosis	0.000225	0.00192	CcSEcCtD
Bumetanide—Dizziness—Methylprednisolone—multiple sclerosis	0.000224	0.00192	CcSEcCtD
Bumetanide—Asthenia—Betamethasone—multiple sclerosis	0.000221	0.00189	CcSEcCtD
Bumetanide—Asthenia—Dexamethasone—multiple sclerosis	0.000221	0.00189	CcSEcCtD
Bumetanide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00022	0.00188	CcSEcCtD
Bumetanide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00022	0.00188	CcSEcCtD
Bumetanide—Nausea—Prednisolone—multiple sclerosis	0.00022	0.00188	CcSEcCtD
Bumetanide—CA5B—Metabolism—SRM—multiple sclerosis	0.000218	0.00344	CbGpPWpGaD
Bumetanide—CA7—Metabolism—SRM—multiple sclerosis	0.000218	0.00344	CbGpPWpGaD
Bumetanide—Pruritus—Dexamethasone—multiple sclerosis	0.000218	0.00186	CcSEcCtD
Bumetanide—Pruritus—Betamethasone—multiple sclerosis	0.000218	0.00186	CcSEcCtD
Bumetanide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000217	0.00185	CcSEcCtD
Bumetanide—Vomiting—Triamcinolone—multiple sclerosis	0.000216	0.00185	CcSEcCtD
Bumetanide—Vomiting—Methylprednisolone—multiple sclerosis	0.000216	0.00184	CcSEcCtD
Bumetanide—Rash—Triamcinolone—multiple sclerosis	0.000214	0.00183	CcSEcCtD
Bumetanide—Dermatitis—Triamcinolone—multiple sclerosis	0.000214	0.00183	CcSEcCtD
Bumetanide—Rash—Methylprednisolone—multiple sclerosis	0.000214	0.00183	CcSEcCtD
Bumetanide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000214	0.00183	CcSEcCtD
Bumetanide—Urticaria—Prednisone—multiple sclerosis	0.000213	0.00182	CcSEcCtD
Bumetanide—Headache—Triamcinolone—multiple sclerosis	0.000213	0.00182	CcSEcCtD
Bumetanide—Headache—Methylprednisolone—multiple sclerosis	0.000212	0.00182	CcSEcCtD
Bumetanide—Abdominal pain—Prednisone—multiple sclerosis	0.000212	0.00181	CcSEcCtD
Bumetanide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000211	0.0018	CcSEcCtD
Bumetanide—Diarrhoea—Betamethasone—multiple sclerosis	0.000211	0.0018	CcSEcCtD
Bumetanide—SLC12A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.00021	0.00332	CbGpPWpGaD
Bumetanide—Hypotension—Methotrexate—multiple sclerosis	0.00021	0.00179	CcSEcCtD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000207	0.00327	CbGpPWpGaD
Bumetanide—Dizziness—Betamethasone—multiple sclerosis	0.000204	0.00174	CcSEcCtD
Bumetanide—Dizziness—Dexamethasone—multiple sclerosis	0.000204	0.00174	CcSEcCtD
Bumetanide—CA12—Metabolism—SRM—multiple sclerosis	0.000202	0.00319	CbGpPWpGaD
Bumetanide—Nausea—Triamcinolone—multiple sclerosis	0.000202	0.00173	CcSEcCtD
Bumetanide—Nausea—Methylprednisolone—multiple sclerosis	0.000201	0.00172	CcSEcCtD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000201	0.00317	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.0002	0.00315	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000199	0.00314	CbGpPWpGaD
Bumetanide—Vomiting—Betamethasone—multiple sclerosis	0.000196	0.00168	CcSEcCtD
Bumetanide—Vomiting—Dexamethasone—multiple sclerosis	0.000196	0.00168	CcSEcCtD
Bumetanide—Rash—Dexamethasone—multiple sclerosis	0.000194	0.00166	CcSEcCtD
Bumetanide—Rash—Betamethasone—multiple sclerosis	0.000194	0.00166	CcSEcCtD
Bumetanide—Dermatitis—Dexamethasone—multiple sclerosis	0.000194	0.00166	CcSEcCtD
Bumetanide—Dermatitis—Betamethasone—multiple sclerosis	0.000194	0.00166	CcSEcCtD
Bumetanide—Fatigue—Methotrexate—multiple sclerosis	0.000194	0.00165	CcSEcCtD
Bumetanide—Headache—Betamethasone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Bumetanide—Headache—Dexamethasone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Bumetanide—Asthenia—Prednisone—multiple sclerosis	0.000193	0.00165	CcSEcCtD
Bumetanide—Pruritus—Prednisone—multiple sclerosis	0.00019	0.00162	CcSEcCtD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000189	0.00298	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000188	0.00297	CbGpPWpGaD
Bumetanide—Diarrhoea—Prednisone—multiple sclerosis	0.000184	0.00157	CcSEcCtD
Bumetanide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000184	0.00157	CcSEcCtD
Bumetanide—Nausea—Dexamethasone—multiple sclerosis	0.000183	0.00157	CcSEcCtD
Bumetanide—Nausea—Betamethasone—multiple sclerosis	0.000183	0.00157	CcSEcCtD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00018	0.00285	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	0.00018	0.00284	CbGpPWpGaD
Bumetanide—Urticaria—Methotrexate—multiple sclerosis	0.000178	0.00152	CcSEcCtD
Bumetanide—Dizziness—Prednisone—multiple sclerosis	0.000178	0.00152	CcSEcCtD
Bumetanide—Abdominal pain—Methotrexate—multiple sclerosis	0.000177	0.00152	CcSEcCtD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	0.000177	0.00279	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000176	0.00278	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	0.000172	0.00272	CbGpPWpGaD
Bumetanide—Vomiting—Prednisone—multiple sclerosis	0.000171	0.00146	CcSEcCtD
Bumetanide—Rash—Prednisone—multiple sclerosis	0.000169	0.00145	CcSEcCtD
Bumetanide—Dermatitis—Prednisone—multiple sclerosis	0.000169	0.00145	CcSEcCtD
Bumetanide—CA14—Metabolism—CYP24A1—multiple sclerosis	0.000169	0.00267	CbGpPWpGaD
Bumetanide—CA14—Metabolism—CYP27B1—multiple sclerosis	0.000169	0.00267	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SRM—multiple sclerosis	0.000169	0.00267	CbGpPWpGaD
Bumetanide—Headache—Prednisone—multiple sclerosis	0.000168	0.00144	CcSEcCtD
Bumetanide—CA5A—Metabolism—CYP24A1—multiple sclerosis	0.000165	0.0026	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—CYP27B1—multiple sclerosis	0.000165	0.0026	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SRM—multiple sclerosis	0.000161	0.00254	CbGpPWpGaD
Bumetanide—Asthenia—Methotrexate—multiple sclerosis	0.000161	0.00138	CcSEcCtD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	0.000161	0.00254	CbGpPWpGaD
Bumetanide—Nausea—Prednisone—multiple sclerosis	0.00016	0.00136	CcSEcCtD
Bumetanide—Pruritus—Methotrexate—multiple sclerosis	0.000159	0.00136	CcSEcCtD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000158	0.00249	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.000158	0.00249	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IFNB1—multiple sclerosis	0.000157	0.00248	CbGpPWpGaD
Bumetanide—CA14—Metabolism—GPC5—multiple sclerosis	0.000155	0.00244	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP27B1—multiple sclerosis	0.000154	0.00243	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP24A1—multiple sclerosis	0.000154	0.00243	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CYP27B1—multiple sclerosis	0.000154	0.00243	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CYP24A1—multiple sclerosis	0.000154	0.00243	CbGpPWpGaD
Bumetanide—Diarrhoea—Methotrexate—multiple sclerosis	0.000154	0.00131	CcSEcCtD
Bumetanide—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	0.000153	0.00242	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000152	0.00239	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GPC5—multiple sclerosis	0.000151	0.00238	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000151	0.00238	CbGpPWpGaD
Bumetanide—Dizziness—Methotrexate—multiple sclerosis	0.000148	0.00127	CcSEcCtD
Bumetanide—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000146	0.0023	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000144	0.00228	CbGpPWpGaD
Bumetanide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	0.000143	0.00226	CbGpPWpGaD
Bumetanide—Vomiting—Methotrexate—multiple sclerosis	0.000143	0.00122	CcSEcCtD
Bumetanide—CA12—Metabolism—CYP24A1—multiple sclerosis	0.000142	0.00225	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CYP27B1—multiple sclerosis	0.000142	0.00225	CbGpPWpGaD
Bumetanide—Rash—Methotrexate—multiple sclerosis	0.000142	0.00121	CcSEcCtD
Bumetanide—Dermatitis—Methotrexate—multiple sclerosis	0.000141	0.00121	CcSEcCtD
Bumetanide—CA7—Metabolism—GPC5—multiple sclerosis	0.000141	0.00222	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GPC5—multiple sclerosis	0.000141	0.00222	CbGpPWpGaD
Bumetanide—Headache—Methotrexate—multiple sclerosis	0.000141	0.0012	CcSEcCtD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00014	0.00221	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000137	0.00216	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000135	0.00212	CbGpPWpGaD
Bumetanide—Nausea—Methotrexate—multiple sclerosis	0.000133	0.00114	CcSEcCtD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000132	0.00208	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000132	0.00208	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000132	0.00208	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GPC5—multiple sclerosis	0.00013	0.00206	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SRM—multiple sclerosis	0.00013	0.00206	CbGpPWpGaD
Bumetanide—CA14—Metabolism—RRM1—multiple sclerosis	0.000128	0.00202	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000127	0.002	CbGpPWpGaD
Bumetanide—SLC12A5—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000126	0.00198	CbGpPWpGaD
Bumetanide—SLC12A4—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000126	0.00198	CbGpPWpGaD
Bumetanide—CFTR—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000126	0.00198	CbGpPWpGaD
Bumetanide—SLC12A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000125	0.00197	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000125	0.00197	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—RRM1—multiple sclerosis	0.000125	0.00197	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP27B1—multiple sclerosis	0.000119	0.00188	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CYP24A1—multiple sclerosis	0.000119	0.00188	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000119	0.00188	CbGpPWpGaD
Bumetanide—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000118	0.00186	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—RRM1—multiple sclerosis	0.000117	0.00184	CbGpPWpGaD
Bumetanide—CA7—Metabolism—RRM1—multiple sclerosis	0.000117	0.00184	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000116	0.00184	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000115	0.00181	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP27B1—multiple sclerosis	0.000114	0.00179	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CYP24A1—multiple sclerosis	0.000114	0.00179	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GPC5—multiple sclerosis	0.000109	0.00172	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000108	0.0017	CbGpPWpGaD
Bumetanide—CA12—Metabolism—RRM1—multiple sclerosis	0.000108	0.0017	CbGpPWpGaD
Bumetanide—SLC12A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000107	0.00169	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000105	0.00166	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000104	0.00164	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GPC5—multiple sclerosis	0.000104	0.00164	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000104	0.00164	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000102	0.00161	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.59e-05	0.00151	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	9.55e-05	0.00151	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	9.33e-05	0.00147	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	9.25e-05	0.00146	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP27B1—multiple sclerosis	9.18e-05	0.00145	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CYP24A1—multiple sclerosis	9.18e-05	0.00145	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	9.08e-05	0.00143	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—RRM1—multiple sclerosis	9.03e-05	0.00142	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	8.7e-05	0.00137	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	8.66e-05	0.00137	CbGpPWpGaD
Bumetanide—CA4—Metabolism—RRM1—multiple sclerosis	8.61e-05	0.00136	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GPC5—multiple sclerosis	8.4e-05	0.00133	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SRM—multiple sclerosis	8.32e-05	0.00131	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.06e-05	0.00127	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	8.03e-05	0.00127	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.95e-05	0.00125	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.95e-05	0.00125	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.9e-05	0.00125	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	7.79e-05	0.00123	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	7.73e-05	0.00122	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.58e-05	0.0012	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	7.56e-05	0.00119	CbGpPWpGaD
Bumetanide—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	7.46e-05	0.00118	CbGpPWpGaD
Bumetanide—CA14—Metabolism—BCHE—multiple sclerosis	7.36e-05	0.00116	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	7.26e-05	0.00114	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	7.2e-05	0.00114	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	7.18e-05	0.00113	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—BCHE—multiple sclerosis	7.17e-05	0.00113	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.13e-05	0.00112	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7e-05	0.00111	CbGpPWpGaD
Bumetanide—CA9—Metabolism—RRM1—multiple sclerosis	6.96e-05	0.0011	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	6.88e-05	0.00109	CbGpPWpGaD
Bumetanide—SLC22A7—SLC-mediated transmembrane transport—ALB—multiple sclerosis	6.77e-05	0.00107	CbGpPWpGaD
Bumetanide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	6.74e-05	0.00106	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.7e-05	0.00106	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—BCHE—multiple sclerosis	6.69e-05	0.00106	CbGpPWpGaD
Bumetanide—CA7—Metabolism—BCHE—multiple sclerosis	6.69e-05	0.00106	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	6.64e-05	0.00105	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	6.62e-05	0.00104	CbGpPWpGaD
Bumetanide—SLC12A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.35e-05	0.001	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	6.34e-05	0.001	CbGpPWpGaD
Bumetanide—CA12—Metabolism—BCHE—multiple sclerosis	6.2e-05	0.000979	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	6.16e-05	0.000972	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.02e-05	0.000949	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	5.91e-05	0.000932	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	5.86e-05	0.000925	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	5.86e-05	0.000925	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.73e-05	0.000904	CbGpPWpGaD
Bumetanide—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.69e-05	0.000897	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.49e-05	0.000865	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	5.43e-05	0.000857	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GPC5—multiple sclerosis	5.36e-05	0.000846	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—STAT3—multiple sclerosis	5.33e-05	0.000841	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	5.24e-05	0.000826	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—BCHE—multiple sclerosis	5.18e-05	0.000818	CbGpPWpGaD
Bumetanide—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.05e-05	0.000797	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SRM—multiple sclerosis	5.02e-05	0.000793	CbGpPWpGaD
Bumetanide—CA4—Metabolism—BCHE—multiple sclerosis	4.95e-05	0.00078	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—MAPK1—multiple sclerosis	4.85e-05	0.000765	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	4.77e-05	0.000753	CbGpPWpGaD
Bumetanide—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.75e-05	0.000749	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	4.67e-05	0.000737	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	4.65e-05	0.000734	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—RRM1—multiple sclerosis	4.44e-05	0.000701	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOE—multiple sclerosis	4.43e-05	0.000698	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	4.4e-05	0.000695	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOE—multiple sclerosis	4.31e-05	0.000681	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	4.29e-05	0.000676	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOE—multiple sclerosis	4.03e-05	0.000635	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOE—multiple sclerosis	4.03e-05	0.000635	CbGpPWpGaD
Bumetanide—CA9—Metabolism—BCHE—multiple sclerosis	4e-05	0.000631	CbGpPWpGaD
Bumetanide—PTGS2—Disease—GPC5—multiple sclerosis	3.87e-05	0.00061	CbGpPWpGaD
Bumetanide—CA14—Metabolism—POMC—multiple sclerosis	3.8e-05	0.0006	CbGpPWpGaD
Bumetanide—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.79e-05	0.000598	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—multiple sclerosis	3.73e-05	0.000589	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—IL6—multiple sclerosis	3.73e-05	0.000588	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—POMC—multiple sclerosis	3.71e-05	0.000585	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	3.64e-05	0.000574	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	3.63e-05	0.000573	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	3.56e-05	0.000562	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP24A1—multiple sclerosis	3.54e-05	0.000558	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CYP27B1—multiple sclerosis	3.54e-05	0.000558	CbGpPWpGaD
Bumetanide—CA14—Metabolism—ALB—multiple sclerosis	3.47e-05	0.000547	CbGpPWpGaD
Bumetanide—CA7—Metabolism—POMC—multiple sclerosis	3.46e-05	0.000546	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—POMC—multiple sclerosis	3.46e-05	0.000546	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.46e-05	0.000546	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	3.46e-05	0.000546	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.45e-05	0.000544	CbGpPWpGaD
Bumetanide—SLC22A7—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.44e-05	0.000543	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	3.39e-05	0.000535	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—ALB—multiple sclerosis	3.38e-05	0.000533	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GPC5—multiple sclerosis	3.24e-05	0.000511	CbGpPWpGaD
Bumetanide—CA12—Metabolism—POMC—multiple sclerosis	3.21e-05	0.000506	CbGpPWpGaD
Bumetanide—CA7—Metabolism—ALB—multiple sclerosis	3.15e-05	0.000498	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—ALB—multiple sclerosis	3.15e-05	0.000498	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—multiple sclerosis	3.12e-05	0.000492	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—multiple sclerosis	2.98e-05	0.000469	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.96e-05	0.000467	CbGpPWpGaD
Bumetanide—CA12—Metabolism—ALB—multiple sclerosis	2.92e-05	0.000461	CbGpPWpGaD
Bumetanide—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.89e-05	0.000456	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	2.73e-05	0.000431	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.7e-05	0.000426	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—RRM1—multiple sclerosis	2.68e-05	0.000423	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—POMC—multiple sclerosis	2.68e-05	0.000423	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.57e-05	0.000405	CbGpPWpGaD
Bumetanide—CA4—Metabolism—POMC—multiple sclerosis	2.56e-05	0.000403	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—BCHE—multiple sclerosis	2.55e-05	0.000402	CbGpPWpGaD
Bumetanide—PTGS2—Disease—RPL5—multiple sclerosis	2.51e-05	0.000397	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.47e-05	0.00039	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.47e-05	0.00039	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—ALB—multiple sclerosis	2.44e-05	0.000385	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.42e-05	0.000382	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.41e-05	0.000381	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC11A1—multiple sclerosis	2.41e-05	0.00038	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—multiple sclerosis	2.4e-05	0.000379	CbGpPWpGaD
Bumetanide—CA4—Metabolism—ALB—multiple sclerosis	2.33e-05	0.000368	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.31e-05	0.000364	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.08e-05	0.000328	CbGpPWpGaD
Bumetanide—CA9—Metabolism—POMC—multiple sclerosis	2.07e-05	0.000326	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD28—multiple sclerosis	1.92e-05	0.000303	CbGpPWpGaD
Bumetanide—CA9—Metabolism—ALB—multiple sclerosis	1.88e-05	0.000297	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.79e-05	0.000282	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.63e-05	0.000257	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—BCHE—multiple sclerosis	1.54e-05	0.000243	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.53e-05	0.000242	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD86—multiple sclerosis	1.37e-05	0.000216	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.32e-05	0.000208	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CCR5—multiple sclerosis	1.22e-05	0.000192	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.2e-05	0.00019	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HLA-A—multiple sclerosis	1.19e-05	0.000187	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—multiple sclerosis	1.11e-05	0.000175	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD80—multiple sclerosis	1e-05	0.000158	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—multiple sclerosis	9.27e-06	0.000146	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TYK2—multiple sclerosis	8.45e-06	0.000133	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—POMC—multiple sclerosis	7.96e-06	0.000126	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD4—multiple sclerosis	7.64e-06	0.000121	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ALB—multiple sclerosis	7.26e-06	0.000115	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—multiple sclerosis	5.91e-06	9.33e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—multiple sclerosis	5.5e-06	8.67e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—multiple sclerosis	5.48e-06	8.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MAPK1—multiple sclerosis	5.38e-06	8.48e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IL6—multiple sclerosis	4.13e-06	6.52e-05	CbGpPWpGaD
